Correction: Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model

doi:10.1136/jitc-2022-005414corr1

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

See original article:

Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model - November 01, 2022

PDF

Correction

Correction: Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model

	Full	Pdf
Jan 2023	166	41
Feb 2023	88	16
Total	254	57

Main menu

See original article:

Online download statistics by month:

Online download statistics by month: January 2023 to March 2023

Log in using your username and password

Main menu

Log in using your username and password

You are here

See original article:

Online download statistics by month:

Online download statistics by month: January 2023 to March 2023

Read the full text or download the PDF:

Log in using your username and password